Literature DB >> 4080651

Cellular response to androgen depletion and repletion in the rat ventral prostate: autoradiography and morphometric analysis.

H F English, J R Drago, R J Santen.   

Abstract

The effect of androgen depletion/repletion on the cell types of the rat ventral prostate has been studied using light microscope autoradiography and morphometric analysis. All prostatic cells were assigned to one of the following groups: epithelial, endothelial, stromal (periacinar), or stromal (interacinar). With the exception of the latter group, the numbers of all other cell types were significantly reduced by androgen depletion (castration), and increased by repletion thereafter. During the repletion period, the labeling index of all cell types rose in parallel and peaked 72 hours postinitiation of androgen replacement. The size of the proliferating pool just prior to the peak day was determined. Forty-five percent of the total prostatic cell population was found to be labeled. The epithelial cell group contained the greatest proportion of labeled cells, but significant percentages occurred in the other types. These results precisely define the temporal effects of androgen replacement on prostatic cell population dynamics in the castrate rat.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4080651     DOI: 10.1002/pros.2990070106

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth.

Authors:  Neville N C Tam; Ying Gao; Yuet-Kin Leung; Shuk-Mei Ho
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 3.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

4.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

5.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

6.  Identification of a stem cell candidate in the normal human prostate gland.

Authors:  Monika Schmelz; Roland Moll; Ulrike Hesse; Anil R Prasad; Jay A Gandolfi; Shirin R Hasan; Marty Bartholdi; Anne E Cress
Journal:  Eur J Cell Biol       Date:  2005-03       Impact factor: 4.492

7.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

8.  Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.

Authors:  Juan Wen; Yuan Zhao; Jinghe Li; Chunyan Weng; Jingjing Cai; Kan Yang; Hong Yuan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2013-02-19       Impact factor: 4.104

9.  Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.

Authors:  Xiaojuan Sun; Hui He; Zhihui Xie; Weiping Qian; Haiyen E Zhau; Leland W K Chung; Fray F Marshall; Ruoxiang Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-10       Impact factor: 2.416

10.  Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell.

Authors:  Alejandro Godoy; Anica Watts; Paula Sotomayor; Viviana P Montecinos; Wendy J Huss; Sergio A Onate; Gary J Smith
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.